fMIFL is an FPR1 agonist that activates several transduction pathways responsible for various neutrophil functions, such as adhesion, chemotaxis, granule secretion through exocytosis, and the production of superoxide anions. It is used in the research of bacterial infections and tissue damage.
Molekulargewicht:
550.71
CAS Nummer:
[112275-26-0]
Formel:
C27H42N4O6S
Target-Kategorie:
Antibacterial
T200583
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten